Adipose Tissue-Derived Mesenchymal Stem Cells Exert In Vitro Immunomodulatory and Beta Cell Protective Functions in Streptozotocin-Induced Diabetic Mice Model
Regenerative and immunomodulatory properties of mesenchymal stem cells (MSCs) might be applied for type 1 diabetes mellitus (T1DM) treatment. Thus, we proposed in vitro assessment of adipose tissue-derived MSCs (AT-MSCs) immunomodulation on autoimmune response along with beta cell protection in stre...
Saved in:
Main Authors: | Hossein Rahavi, Seyed Mahmoud Hashemi, Masoud Soleimani, Jamal Mohammadi, Nader Tajik |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2015-01-01
|
Series: | Journal of Diabetes Research |
Online Access: | http://dx.doi.org/10.1155/2015/878535 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Exposure to Osteoarthritic Synovial Fluid Enhances the Immunomodulatory Profile of Adipose Mesenchymal Stem Cell Secretome
by: Adriana Cifù, et al.
Published: (2020-01-01) -
The Immunomodulatory Properties of Mesenchymal Stem Cells
by: Junji Xu, et al.
Published: (2018-01-01) -
Immunomodulatory Functions of Mesenchymal Stem Cells in Tissue Engineering
by: Haojiang Li, et al.
Published: (2019-01-01) -
The Immunomodulatory Potential of Wharton’s Jelly Mesenchymal Stem/Stromal Cells
by: Fernanda Vieira Paladino, et al.
Published: (2019-01-01) -
The Potential Use of Mesenchymal Stem Cells and Their Derived Exosomes as Immunomodulatory Agents for COVID-19 Patients
by: Faisal A. Alzahrani, et al.
Published: (2020-01-01)